Shineco, Inc. (SISI)

OTCMKTS · Delayed Price · Currency is USD
0.24055
+0.07395 (44.39%)
At close: May 1, 2026
Market Cap216.64K -96.3%
Revenue (ttm)9.60M +1,133.3%
Net Income-38.90M
EPS-422.46
Shares Out900.61K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume183
Average Volume2,142
Open0.2406
Previous Close0.1666
Day's Range0.2406 - 0.2406
52-Week Range0.0039 - 54.9950
Beta-2.23
RSI46.77
Earnings DateMay 18, 2026

About Shineco

Shineco, Inc., through its subsidiaries, plants, processes, and distributes agricultural produce. The company also engages in the development, production, and distribution of diagnostic products and related medical devices; trading of fresh fruits; and processing, producing, and distribution of silk and silk fabrics, as well as other by-products. In addition, it operates a restaurant in Fuzhou. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. Shineco, Inc. was incorporated in 1997 and is based in Beijing,... [Read more]

Industry Farm Products
Founded 1997
Employees 119
Stock Exchange OTCMKTS
Ticker Symbol SISI
Full Company Profile

Financial Performance

In fiscal year 2024, Shineco's revenue was $9.80 million, an increase of 1680.61% compared to the previous year's $550,476. Losses were -$22.45 million, 68.0% more than in 2023.

Financial Statements

News

Shineco signs $8.7M tech services contract, announces BICC collaboration

Shineco (SISI) subsidiary, Xi’an Dong’ao Health Management has signed a technology services contract valued at $8.7M with Xinke Future Biotechnology for the research and development of “microalgae-der...

8 months ago - TheFly

Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines

BEIJING , Sept. 12, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, today an...

8 months ago - PRNewsWire

Shineco unit achieves mass production of high-purity soybean phospholipids

Shineco (SISI) announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. ...

8 months ago - TheFly

Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries

BEIJING , Sept. 10, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced tha...

8 months ago - PRNewsWire

Shineco enters strategic cooperation agreement with BICC

Shineco (SISI) has entered into a strategic cooperation agreement with Singapore-based BICC to jointly promote the implementation and redemption of “on-chain cell assets” across multiple institutions ...

9 months ago - TheFly

Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth

BEIJING , Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strateg...

9 months ago - PRNewsWire

Shineco Stock (SISI) Rockets 45% on Cellular Blockchain Agreement

Shineco stock rallied on Wednesday after the company announced a cellular blockchain agreement.

9 months ago - TipRanks

Shineco, Plus Me execute cooperation agreement

Shineco (SISI) announced the execution of a “Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement” with blockchain infrastructure provider Plus Me Limited. This partnership enables...

9 months ago - TheFly

Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech Network

BEIJING , Aug. 20, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a leading innovator in induced pluripotent stem cell (iPSC) technology, today announced the execution o...

9 months ago - PRNewsWire

Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology

BEIJING , Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establ...

9 months ago - PRNewsWire

Shineco Inc trading halted, news pending

19:50 EDT Shineco (SISI) Inc trading halted, news pending

9 months ago - TheFly

Shineco to effect 50-for-1 reverse stock split

Shineco’s (SISI) Board of Directors has approved a 50:1 reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share to be effective 12:01 a.m.,…

9 months ago - TheFly

Shineco, Inc. to Effect 50:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price BEIJING, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (Nasdaq:SISI) ("Shineco" or the "Company"), a provider of innov...

9 months ago - GlobeNewsWire

Shineco executives launch up to $2M open-market stock purchase program

Shineco (SISI) announced that Ms. Jennifer Zhan, the CEO, and Mr. Sam Wang, the Company’s CFO, will jointly initiate a stock purchase program to purchase up to $2,000,000 of the…

11 months ago - TheFly

Shineco subsidiary partners with Total World Marketing

Shineco (SISI) announced that InfiniClone, Shineco’s majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market...

1 year ago - TheFly

Shineco subsidiary to acquire 51% equity interest in InfiniClone

Shineco (SISI) announced that on April 22, 2025, its subsidiary, Shineco Life Sciences Group Hong Kong, entered into a Share Purchase Agreement with Dr. Lim Kah Meng to acquire 51%…

1 year ago - TheFly

Shineco announces acquisition of medical device company

Shineco (SISI) announced that on March 20, 2025, Shineco Life Science Group Hong Kong Co., a subsidiary of the Company, entered into a Stock Purchase Agreement with Yi Yang, for…

1 year ago - TheFly

Shineco Announces Acquisition of Medical Device Company

The Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business  BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NA...

1 year ago - GlobeNewsWire

Shineco files to sell 15M shares of common stock for holders

16:36 EST Shineco (SISI) files to sell 15M shares of common stock for holders

1 year ago - TheFly

Shineco files to sell 15M shares of common stock for holders

16:11 EST Shineco (SISI) files to sell 15M shares of common stock for holders

1 year ago - TheFly

Shineco announces 1-for-24 reverse stock split

Shineco (SISI) announced that effective at 12:01 a.m., EDT, on November 12, 2024, the Company will effect a one-for-twenty four reverse stock split of its outstanding common stock. The Reverse…

1 year ago - TheFly

Shineco Inc trading halted, news pending

19:50 EST Shineco (SISI) Inc trading halted, news pending

1 year ago - TheFly

Future FinTech Announces the Appointment of Hu Li as the New CEO

NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technolo...

1 year ago - PRNewsWire

Shineco Announces Closing of $2 Million Underwritten Public Offering

Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced ...

1 year ago - GlobeNewsWire

Shineco prices 1.87M shares at $1.07 in underwritten public offering

Shineco announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate…

1 year ago - TheFly